awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36631654-9A60110E-46BC-4DAB-B056-AB4AA53C0DCB
Q36631654-9A60110E-46BC-4DAB-B056-AB4AA53C0DCB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36631654-9A60110E-46BC-4DAB-B056-AB4AA53C0DCB
Drug Insight: new drugs in development for Parkinson's disease.
P2860
Q36631654-9A60110E-46BC-4DAB-B056-AB4AA53C0DCB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36631654-9A60110E-46BC-4DAB-B056-AB4AA53C0DCB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b74c8942b3addfa8c09e5afb5447f1cb9f0f8a9a
P2860
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.